LCI-765

N/A

Report date: 2021/12/28 13:57:07
NME

Base Information

Drug NameLCI-765
Drug Alias NameLCI-765
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPeroxisome proliferator-activated receptor delta agonists
TargetsPeroxisome proliferator-activated receptor delta
Therapy Area/IndicationsMetabolic Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesNovartis Pharma Ag
Inactive CompaniesN/A
Active IndicationsMetabolic Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A